OXY
48
3
JCI
31
3
BSX
69
-2
TSCO
50
-6
VTR
70
7
TAP
50
2
VNO
59
4
FE
52
2
IRM
59
-4
REGN
66
4
DO
60
6
LOW
56
3
KSS
34
6
FMC
43
4
NOC
43
-5
SYY
50
2
URBN
58
6
PFE
40
7
BRK.B
49
2
ECL
84
2
OXY
48
3
JCI
31
3
BSX
69
-2
TSCO
50
-6
VTR
70
7
TAP
50
2
VNO
59
4
FE
52
2
IRM
59
-4
REGN
66
4
DO
60
6
LOW
56
3
KSS
34
6
FMC
43
4
NOC
43
-5
SYY
50
2
URBN
58
6
PFE
40
7
BRK.B
49
2
ECL
84
2
Financhill
Back

Alaris Equity Partners Income Trust Vs. Xtacy Therapeutics Industry Stock Comparison

Buy
64

AD.UN.TO
Alaris Equity Partners Income Trust

Last Price:
15.88
Seasonality Move:
7.44%
Buy
54

XTCY.CX
Xtacy Therapeutics

Last Price:
0.05
Seasonality Move:
-11.15%
Buy
64
Alaris Equity Partners Income Trust (AD.UN.TO) is a Buy

Is Alaris Equity Partners Income Trust a Buy, Sell or Hold?

  • The current Alaris Equity Partners Income Trust [AD.UN.TO] share price is $15.74. The Score for AD.UN.TO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • AD.UN.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Xtacy Therapeutics (XTCY.CX) is a Buy

Is Xtacy Therapeutics a Buy, Sell or Hold?

  • The current Xtacy Therapeutics [XTCY.CX] share price is $0.05. The Score for XTCY.CX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • XTCY.CX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AD.UN.TO Stock Price Chart

What is Alaris Equity Partners Income Trust's stock price today?

  • The Alaris Equity Partners Income Trust share price today is $15.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AD.UN.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

XTCY.CX Stock Price Chart

What is Xtacy Therapeutics's stock price today?

  • The Xtacy Therapeutics share price today is $0.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XTCY.CX is experiencing slight buying pressure.

AD.UN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 42.11 Sell
Chaikin Money Flow: 19306 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.56 - 16.64) Sell
Bollinger Bands (100): (15.91 - 16.77) Sell

XTCY.CX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 55.14 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.03 - 0.05) Buy
Bollinger Bands (100): (0.04 - 0.06) Sell

AD.UN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.65 Buy
20-day SMA: 15.93 Sell
50-day SMA: 16.34 Sell
200-day SMA: 15.45 Buy
8-day EMA: 15.68 Buy
20-day EMA: 15.9 Sell
50-day EMA: 16.16 Sell
200-day EMA: 15.92 Sell

XTCY.CX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.05 Buy
20-day SMA: 0.04 Buy
50-day SMA: 0.05 Buy
200-day SMA: 0.05 Sell
8-day EMA: 0.04 Buy
20-day EMA: 0.04 Buy
50-day EMA: 0.05 Buy
200-day EMA: 0.06 Sell

Alaris Equity Partners Income Trust Earnings Growth & AD.UN.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alaris Equity Partners Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Xtacy Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):